AML | Age 87 | New Dx
AML Specialist
Hematologist, Oncologist
What are your thoughts on the diagnosis and treatment options for an ECOG 3 patient with 17% myeloid blasts on peripheral flow results?
Read ResponseMultiple Myeloma | Age 51 | R/R
Multiple Myeloma Specialist
Hematologist, Oncologist
New diagnosed myeloma patient with expansile lytic mass along with diffuse lytic lesions. Do I need to biopsy the mass? What do you use for induction treatment of high-risk disease?
Read ResponseBreast Cancer | Age 60
Breast Cancer Specialist
Hematologist, Oncologist
What statistics do you provide patients regarding the benefits of endocrine therapy over placebo for invasive breast cancer and for DCIS?
Read ResponseGI Cancer | Age 55 | New Dx
GI Cancer Specialist
Hematologist, Oncologist
For GE junction with gastric adeno T3N1 would you recommend concurrent chemo rad or preop Chemo?
Read ResponseNon-Hodgkin Lymphoma | Age 50 | R/R
Non-Hodgkin Lymphoma Specialist
Hematologist, Oncologist
Relapsed follicular lymphoma patient being treated with R-DHAP, but concerned about collection. Planning on CAR-T but would you consider doing a BEAM auto and holding CAR-T in reserve?
Read ResponseMultiple Myeloma | Age 70 | R/R
Multiple Myeloma Specialist
I have a myeloma patient who has 8 lines of therapy and a good performance status. What would be your recommendation for their next line of treatment?
Read Response